Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

Editorial | An Easy Approach to Reduce Prescription Medication Costs in the United States – MIR

11 Jan, 2026

Anticipations for AbbVie's Immunology Division in the Fourth Quarter

09 Jan, 2026

Anticipations for AbbVie's Immunology Division in the Fourth Quarter - TradingView

09 Jan, 2026

The 2026 Income Stronghold: Reasons Big Pharma is the Safe Investment for the Upcoming Year

30 Dec, 2025

See More